Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03737734 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Dec 2026v13
  2. Primary completion date: Dec 2024 to Dec 2025v12
  3. Re-verified, no change to tracked fieldsv11
  4. Primary completion date: Dec 2023 to Dec 2024v10
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Re-verified, no change to tracked fieldsv8
  2. Primary completion date: Dec 2022 to Dec 2023
    • Study completion date: Dec 2024 to Dec 2025
    v7
  3. Primary completion date: Dec 2020 to Dec 2022
    • Study completion date: Dec 2022 to Dec 2024
    v6
  4. Secondary endpoints: details revised at 3 of 6 entries
    • Site contact updated
    v5
  5. Re-verified, no change to tracked fieldsv4
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2018 to Dec 31, 2018
    • Secondary endpoints: 5 to 6
    • Site details revised
    v3
  7. Secondary endpoints: 4 to 5v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Trial Details
NCT Number NCT03737734
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Related terms Basal Cell Carcinoma, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov